Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 32024R0568R(01)

Corrigendum to Regulation (EU) 2024/568 of the European Parliament and of the Council of 7 February 2024 on fees and charges payable to the European Medicines Agency, amending Regulations (EU) 2017/745 and (EU) 2022/123 of the European Parliament and of the Council and repealing Regulation (EU) No 658/2014 of the European Parliament and of the Council and Council Regulation (EC) No 297/95 (OJ L, 2024/568, 14.2.2024)

ST/6799/2024/INIT

OJ L, 2024/90247, 23.4.2024, ELI: http://data.europa.eu/eli/reg/2024/568/corrigendum/2024-04-23/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

ELI: http://data.europa.eu/eli/reg/2024/568/corrigendum/2024-04-23/oj

European flag

Official Journal
of the European Union

EN

L series

2024/90247

23.4.2024

Corrigendum to Regulation (EU) 2024/568 of the European Parliament and of the Council of 7 February 2024 on fees and charges payable to the European Medicines Agency, amending Regulations (EU) 2017/745 and (EU) 2022/123 of the European Parliament and of the Council and repealing Regulation (EU) No 658/2014 of the European Parliament and of the Council and Council Regulation (EC) No 297/95

( Official Journal of the European Union L, 2024/568, 14 February 2024 )

1.

 On page 31, Annex IV, Section 4, first sentence:

for:

‘The fee for the re-examination of an opinion of any of the committees referred to in Article 56(1) of Regulation (EC) No 726/2004 and in Article 139(1) of Regulation (EU) 2019/6 shall be 30 % of the fee applicable to the initial opinion in accordance with Sections 3, 4, 5 and 6 of Annex I and Sections 3, 4, 6 and 7 of Annex II to this Regulation.’,

read:

‘The fee for the re-examination of an opinion of any of the committees referred to in Article 56(1) of Regulation (EC) No 726/2004 and in Article 139(1) of Regulation (EU) 2019/6 shall be 30 % of the fee applicable to the initial opinion in accordance with Sections 2, 4, 5 and 6 of Annex I and Sections 3, 4, 6 and 7 of Annex II to this Regulation.’.

2.

 On page 37, Annex V, Section 8:

for:

‘Annual fee for veterinary medicinal products

A fee reduction of 25 % shall apply to the annual fee for veterinary medicinal products set out in Section 2 of Annex III, with the exclusion of those products already listed in Sections 4 and 5 of this Annex.’,

read:

‘Annual fee for veterinary medicinal products

A fee reduction of 25 % shall apply to the annual fee for veterinary medicinal products set out in Section 2 of Annex III, with the exclusion of those products already listed in Sections 5 and 6 of this Annex.’.

ELI: http://data.europa.eu/eli/reg/2024/568/corrigendum/2024-04-23/oj

ISSN 1977-0677 (electronic edition)

Top